TY - DATA T1 - Additional file 2: of Observational study on the prognostic value of testosterone and adiposity in postmenopausal estrogen receptor positive breast cancer patients PY - 2018/06/13 AU - Elisabetta Venturelli AU - Annalisa Orenti AU - Aline Fabricio AU - Giulia Garrone AU - Roberto Agresti AU - Biagio Paolini AU - Chiara Bonini AU - Massimo Gion AU - Franco Berrino AU - Christine Desmedt AU - Danila Coradini AU - Elia Biganzoli UR - https://springernature.figshare.com/articles/journal_contribution/Additional_file_2_of_Observational_study_on_the_prognostic_value_of_testosterone_and_adiposity_in_postmenopausal_estrogen_receptor_positive_breast_cancer_patients/6505151 DO - 10.6084/m9.figshare.6505151.v1 L4 - https://ndownloader.figshare.com/files/11964560 KW - Testosterone KW - Body mass index KW - Estrogen receptor KW - Postmenopausal women KW - Breast cancer N2 - Figure S2. Boxplots of circulating level of testosterone (ng/mL) according to tumour histology (IDC = Invasive Ductal Carcinoma; ILC = Invasive Lobular Carcinoma), Grade (G), number of metastatic axillary lymph Nodes (N), progesterone receptor (PR) and HER-2 status of ER-positive postmenopausal breast cancer patients. Number and percentage of patients in each group are reported and p-values are given. The bar inside the box is the median value and the box upper and lower dimensions define the inter-quartile range. Shows the boxplots of circulating level of testosterone (ng/mL) according to the other tumour characteristics considered in the study (histology, tumour grade, axillary nodal status, PR and HER-2 status). On the whole, the results did not indicate an association between circulating level of testosterone and unfavorable tumour characteristics as high tumour grade, axillary involvement or HER2 overexpression. (PDF 22 kb) ER -